1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To comprehensively assess the reporting quality of randomized, controlled trials (RCTs) in nasopharyngeal carcinoma (NPC), and to identify significant predictors of quality.

          Related collections

          Author and article information

          Journal
          Int. J. Radiat. Oncol. Biol. Phys.
          International journal of radiation oncology, biology, physics
          Elsevier BV
          1879-355X
          0360-3016
          May 01 2017
          : 98
          : 1
          Affiliations
          [1 ] Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.
          [2 ] Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China.
          [3 ] Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.
          [4 ] Department of Radiation Oncology, National Cancer Centre Singapore, Singapore.
          [5 ] Department of Radiation Oncology, University of Toronto; Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.
          [6 ] Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
          [7 ] Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.
          [8 ] Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.
          [9 ] Department of Medical Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.
          [10 ] Clinical Trials Centre, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.
          [11 ] Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, People's Republic of China.
          [12 ] Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China. Electronic address: majun2@mail.sysu.edu.cn.
          Article
          S0360-3016(17)30276-6
          10.1016/j.ijrobp.2017.01.214
          28586958
          17e5a58c-dcfa-4027-8c1e-81f7ee0a9c62
          History

          Comments

          Comment on this article